usamicro_0335|ALRN|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
usamicro_0335|ALRN|1|Aileron Therapeutics Inc Total Current Assets (Quarterly) (USD)|Aileron Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Aileron Therapeutics Inc Inventories (Quarterly) (USD)|Aileron Therapeutics Inc Net PP&E (Quarterly) (USD)|Aileron Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Aileron Therapeutics Inc Total Liabilities (Quarterly) (USD)|Aileron Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Aileron Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Aileron Therapeutics Inc Total Deposits (Quarterly) (USD)|Aileron Therapeutics Inc Book Value (Quarterly) (USD)|Aileron Therapeutics Inc Retained Earnings (Quarterly) (USD)|Aileron Therapeutics Inc Treasury Stock (Quarterly) (USD)|Aileron Therapeutics Inc EV to Revenues|Aileron Therapeutics Inc EV to Earnings|Aileron Therapeutics Inc EV to Free Cash Flow|Aileron Therapeutics Inc EV to Assets (Quarterly)|Aileron Therapeutics Inc PS Ratio|Aileron Therapeutics Inc PE Ratio|Aileron Therapeutics Inc Price to Book Value|Aileron Therapeutics Inc PEG Ratio|Aileron Therapeutics Inc Debt to Equity Ratio|Aileron Therapeutics Inc Dividend Yield|Aileron Therapeutics Inc Shareholder Yield (TTM)|Aileron Therapeutics Inc Percent of Shares Outstanding Short|Aileron Therapeutics Inc Total Receivables (Quarterly) (USD)|Aileron Therapeutics Inc Total Payables (Quarterly) (USD)|Aileron Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Aileron Therapeutics Inc Return on Invested Capital|Aileron Therapeutics Inc Quality Ratio Score|Aileron Therapeutics Inc Momentum Score|Aileron Therapeutics Inc Beta (1Y)|Aileron Therapeutics Inc Sustainable Growth Rate (TTM)|Aileron Therapeutics Inc Institutional Investor Ownership Percentage|Aileron Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Aileron Therapeutics Inc Total Employees (Annual)|Aileron Therapeutics Inc EPS Diluted (Quarterly) (USD)|Aileron Therapeutics Inc Shares Outstanding|Aileron Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Aileron Therapeutics Inc Ordinary Shares Number (Quarterly)|Aileron Therapeutics Inc Payout Ratio|Aileron Therapeutics Inc Quick Ratio (Quarterly)|Aileron Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Aileron Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Aileron Therapeutics Inc Effective Tax Rate (TTM)|Aileron Therapeutics Inc Return on Equity|Aileron Therapeutics Inc Net Income (TTM) (USD)|Aileron Therapeutics Inc Revenue (TTM) (USD)|Aileron Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Aileron Therapeutics Inc Revenue (Quarterly) (USD)|Aileron Therapeutics Inc Gross Profit (Quarterly) (USD)|Aileron Therapeutics Inc SG&A Expense (Quarterly) (USD)|Aileron Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Aileron Therapeutics Inc Net Income (Quarterly) (USD)|Aileron Therapeutics Inc Net Interest Income (Quarterly) (USD)|Aileron Therapeutics Inc Price (USD)|Aileron Therapeutics Inc Total Return Price (USD)|Aileron Therapeutics Inc Enterprise Value (USD)|Aileron Therapeutics Inc 30-Day Average Daily Volume|Aileron Therapeutics Inc 1 Year Price Returns (Daily)||
usamicro_0335|ALRN|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
usamicro_0335|ALRN|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|daily|daily||
usamicro_0335|ALRN|5|91.2142857143|91.2142857143|0|91.2142857143|0|91.2142857143|91.2142857143|91.2142857143|0|91.2142857143|91.2142857143|0|0|0|7.00578034682|0|0|0|7.00578034682|0|0|1.44976076555|0|15.2307692308|0|91.2142857143|91.2142857143|0|0|30.4615384615|30.4814814815|0|30.5|91.2941176471|472|91.2941176471|29.975|0|91.2142857143|0|0|91.2941176471|91.2666666667|0|0|91.2142857143|0|0|0|0|91.2941176471|91.2941176471|91.2941176471|91.2941176471|7.00578034682|7.00578034682|7.00578034682|6.96428571429|1.45034246575||
usamicro_0335|ALRN|6|14|14|0|14|0|14|14|14|0|14|14|0|0|0|173|0|0|0|173|0|0|836|0|78|0|14|14|0|0|26|27|0|14|17|2|17|40|0|14|0|0|17|15|0|0|14|0|0|0|0|17|17|17|17|173|173|173|168|584||
usamicro_0335|ALRN|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
usamicro_0335|ALRN|201603||||||||||||||||||||||||||||||||||10.9144||-0.3613||||||-0.3596|||||||||1.446|-3.925|-3.925|0.014|||||||
usamicro_0335|ALRN|201606||||||||||||||||||||||||||||||||||10.9144||-0.5088||||||-0.507|||||||||3.464|-5.534|-5.534|0.016|||||||
usamicro_0335|ALRN|201609||||||||||||||||||||||||||||||||||10.9144||-0.3886||||||-0.3868|0||||||||1.627|-4.222|-4.222|0.01|||||||
usamicro_0335|ALRN|201612|21.073|20.715||0.107||133.827|4.071|129.756||-111.806|-114.342|||||||||||||||1.971|0|||||||10.9144||-0.4086|||10.9607|||-0.407|0|||-18.123|||||1.356|-4.442|-4.442|0.006|||||||
usamicro_0335|ALRN|201703|15.982|15.294||0.123||2.875|2.871|0.004||14.28|-118.899|||||||||||||||1.035|0.011|||||||14.7102|15|-0.3111|||14.7102|||-0.3098||||-18.755|||||1.647|-4.557|-4.557|0.032|||||||
usamicro_0335|ALRN|201706|11.992|11.343||0.109||135.883|5.471|130.412||-120.778|-123.822||||-8.3387||||11.1254|||0||0||2.212|0|||||||0.4505||-10.98|10.9607||10.9607|||-10.98||||-18.144|||||1.791|-4.923|-4.923|0.029|10.8|10.8|143.5762|41061.5333||13.11|11.66
usamicro_0335|ALRN|201709|58.117|56.865||0.111||5.023|5.023|0||54.013|-130.081||||-9.5719||||3.6025|||0||0.5181||1.65|0.015|||||||13.9399||-0.45|14.7188||14.7188|||-0.45|-52.313|||-20.181|||||2.601|-6.259|-6.259|0.167|12.23|12.23|168.619|64009.1333||13.18|11.29
usamicro_0335|ALRN|201712|51.84|50.752||0.154||4.891|4.891|0||47.797|-136.946||||-5.1924||||2.8722|||0||0.4155||1.6|0.015|||||||14.7238||-0.4663|14.7238||14.7238|||-0.4663|0|||-22.604|||||2.73|-6.865|-6.865|0.176|10.38|10.38|98.2712|24602.4333||9.23|8.21
usamicro_0335|ALRN|201803|44.446|43.291||0.134||4.856|4.856|0||40.975|-144.534||||-3.6701||||2.6492|||0||0.7504||1.796|0.015|||||||14.7323||-0.52|14.7344||14.7344|||-0.52||||-25.635|||||2.917|-7.588|-7.588|0.175|8.04|8.04|75.8727|26295.3||5.67|5.23
usamicro_0335|ALRN|201806|37.206|35.791||4.123||9.709|6.364|3.345||32.868|-154.025||||-1.6037||||1.9026|||0||0.8701||1.583|0.015|||1|0.562|||14.7372||-0.64|14.7374||14.7374|||-0.64|0|||-30.203|||||4.339|-9.491|-9.491|0.168|5.2|5.2|34.6698|44586|-49.8148|3.54|3.06
usamicro_0335|ALRN|201809|30.053|27.945||6.832||12.102|7.105|4.997||26.031|-161.459||||-0.3554||||1.3676|||0||0.7213||2.994|0.015|||1|-1.0554|||14.7374||-0.5|14.7374||14.7374|||-0.5|0|||-31.378|||||3.177|-7.434|-7.434|0.064|2.9|2.9|9.1581|133555.3667|-77.5143|2.27|2.17
usamicro_0335|ALRN|201812|21.775|20.695||7.29||10.712|5.37|5.342||19.6|-168.493||||0.5891||||0.4023|||0||0.2536||1.731|0.015|||1|1.7005|||14.7458|23|-0.48|14.7485||14.7485|||-0.48|0|||-31.547|||||3.021|-7.034|-7.034|-0.052|0.8627|0.8627|-17.4736|126453.7667|-92.8709|1.13|1.61
usamicro_0335|ALRN|201903|14.389|13.27||6.941||9.552|4.623|4.929||12.847|-175.979||||-0.1834||||1.3585|||0||3.1434||0.858|0.015|||1|4.0926|||14.8163||-0.49|14.875||14.875|||-0.49||||-31.172|||||3.139|-7.213|-7.213|0.1|1.95|1.95|5.9312|337180.6333|-76.6169|1.78|1.02
usamicro_0335|ALRN|201906|32.559|31.522||6.764||10.209|5.387|4.822||29.984|-183.151||||-0.2128||||1.5803|||0||1.3373||1.719|0.028|||1|3.1416||63.7887|27.5261||-0.26|26.7136||26.7136|||-0.26|-23.865|||-28.853|||||3.075|-7.172|-7.172|0.207|0.76|0.76|7.0323|171922.2|-86.1538|0.51|0.7951
usamicro_0335|ALRN|201909|26.497|24.561||6.585||11.136|6.428|4.708||22.816|-190.9||||0.2895||||0.7513|||0||0.5815||2.349|0.028|||1|3.1019||51.2967|27.8104||-0.28|27.8104||27.8104|||-0.28|0.051|||-29.168|||||3.44|-7.749|-7.749|0.166|0.8154|0.8154|-8.5006|379801.5|-71.4552|0.46|0.4699
usamicro_0335|ALRN|201912|19.55|18.278||6.355||10.425|5.839|4.586||16.048|-198.135||||0.2697||||0.7349|||0||1.879||1.452|0.028|||1|2.0124||32.9759|27.8463|13|-0.25|27.8104||27.8104|||-0.25|0.015|||-29.369|||||2.639|-7.235|-7.235|0.114|0.573|0.573|-7.3186|281930.8667|-16.2162|0.7297|0.6296
usamicro_0335|ALRN|202003|13.687|12.695||6.118||10.604|6.143|4.461||9.769|-204.883||||0.2896||||0.6585|||0||0.3866||1.088|0.028|||2|1.3905||40.1607|27.8104||-0.24|27.8104||27.8104|||-0.2424||||-28.904|||||2.807|-6.748|-6.748|0.062|0.3713|0.3713|-8.2412|173837.7333|-79.838|0.56|0.9135
usamicro_0335|ALRN|202006|19.67|18.88||5.887||9.471|4.926|4.545||16.654|-209.273||||-1.2991||||4.5801|||0||2.2183||0.993|0.039|||9|4.7516||26.0927|31.2211||-0.14|39.2616||39.2616|||-0.14|-10.876|||-26.122|||||1.912|-4.39|-4.39|0.01|1.18|1.18|27.8327|1452545.8333|63.8889|0.955|1.23
usamicro_0335|ALRN|202009|15.974|14.121||5.697||9.781|5.249|4.532||12.458|-214.296||||-1.3187||||3.0149|||0||1.8973||1.002|0.04|||9|4.4058||16.8262|39.3212||-0.13|39.8748||39.8748|||-0.13|-0.298|||-23.396|||||2.344|-5.023|-5.023|0.005|1.22|1.22|30.1208|434905.8|47.3786|1.28|1.05
usamicro_0335|ALRN|202012|16.326|13.805||0.015||4.179|3.96|0.219||12.162|-219.292||||-1.4211||||3.625|||||3.5537||1.596|0.044|||9|3.5035||35.1538|41.0425|8|-0.12|43.8042||43.8042|||-0.12|-4.239|||-21.157|||||2.267|-4.996|-4.996||1.02|1.02|29.0891|925440.2|64.5161|2.02|1.62
usamicro_0335|ALRN|202103|64.324|63.351||0.326||3.252|3.073|0.179||61.419|-226.267||||-5.3792||||10.1619|||||1.8661||0.56|0.09|||9|2.0779||48.5766|83.3844||-0.08|90.2106||90.2106|||-0.08|-55.604|||-21.384|||||2.673|-6.975|-6.975|0.014|1.37|1.37|110.1705|1836271.6|268.9739|1.19|1.21
usamicro_0335|ALRN|202106|60.152|59.479||0.355||4.401|4.273|0.128||56.13|-231.953||||-2.6752||||1.956|||||1.2916||1.016|0.09|||1|-1.1306||49.0943|90.4586||-0.06|90.5279||90.5279|||-0.06|0.021|||-22.68|||||2.156|-5.686|-5.686|0.019|1.33|1.33|57.169|456374.5667|12.7119|1.03|1.15
usamicro_0335|ALRN|202109|54.423|52.232||0.321||4.659|4.56|0.099||50.109|-238.657||||-1.6792||||1.6617|||||1.2839||1.035|0.091|||3|-1.3503||43.6499|90.549||-0.07|90.5726||90.5726|||-0.07||||-24.361|||||2.513|-6.704|-6.704|0.021|1.03|1.03|33.7914|773165.4333|-18.254|0.9075|0.6169
usamicro_0335|ALRN|202112|||||||||||||||0.1896||||0.9578|||||0.2051||||||2|-2.2071||42.6504||||||||||||||||||||||0.5299|0.5299|-4.237|576218.2667|-52.2613|0.4101|0.427